Improvement of outcomes for TP53 carriers

被引：4
|
作者：
Plon, Sharon E. [1 ]
机构：
[1] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA
来源：
LANCET ONCOLOGY | 2016年 / 17卷 / 09期
关键词：
GERMLINE MUTATIONS; SURVEILLANCE; OVARIAN; CANCER; BREAST; GENES; RISK;
D O I：
10.1016/S1470-2045(16)30382-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1184 / 1186
页数：4
相关论文
共 50 条
  • [31] Transmission of germline TP53 mutations from male carriers to female partners
    Patrier-Sallebert, Sophie
    Bougeard, Gaelle
    Baert-Desurmont, Stephanie
    Lamy, Aude
    Flaman, Jean-Michel
    Mansuy, Ludovic
    Bronner, Myriam
    Lasset, Christine
    Brugieres, Laurence
    Golfier, Francois
    Frebourg, Thierry
    [J]. JOURNAL OF MEDICAL GENETICS, 2015, 52 (03) : 145 - 146
  • [32] Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas
    Galic, Vijaya
    Willner, Julia
    Wollan, Melissa
    Garg, Ruchi
    Garcia, Rochelle
    Goff, Barbara A.
    Gray, Heidi J.
    Swisher, Elizabeth M.
    [J]. GENES CHROMOSOMES & CANCER, 2007, 46 (03): : 239 - 247
  • [33] Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
    Bougeard, Gaelle
    Renaux-Petel, Mariette
    Flaman, Jean-Michel
    Charbonnier, Camille
    Fermey, Pierre
    Belotti, Muriel
    Gauthier-Villars, Marion
    Stoppa-Lyonnet, Dominique
    Consolino, Emilie
    Brugieres, Laurence
    Caron, Olivier
    Benusiglio, Patrick R.
    Bressac-de Paillerets, Brigitte
    Bonadona, Valerie
    Bonaiti-Pellie, Catherine
    Tinat, Julie
    Baert-Desurmont, Stephanie
    Frebourg, Thierry
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (21) : 2345 - U33
  • [34] Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
    Meis Omran
    Lennart Blomqvist
    Yvonne Brandberg
    Niklas Pal
    Per Kogner
    Anne Kinhult Ståhlbom
    Emma Tham
    Svetlana Bajalica-Lagercrantz
    [J]. Hereditary Cancer in Clinical Practice, 18
  • [35] TP53 and ovarian cancer
    Schuijer, M
    Berns, EMJJ
    [J]. HUMAN MUTATION, 2003, 21 (03) : 285 - 291
  • [36] TP53: an oncogene in disguise
    Soussi, T.
    Wiman, K. G.
    [J]. CELL DEATH AND DIFFERENTIATION, 2015, 22 (08): : 1239 - 1249
  • [37] TP53 in Myelodysplastic Syndromes
    Jiang, Yan
    Gao, Su-Jun
    Soubise, Benoit
    Douet-Guilbert, Nathalie
    Liu, Zi-Ling
    Troadec, Marie-Berengere
    [J]. CANCERS, 2021, 13 (21)
  • [38] THE WAYS OF ACTIVATING TP53
    Polaskova, A.
    Helma, R.
    Adamik, M.
    Hronesova, L.
    Holacka, K.
    Ballova, L.
    Brazdova, M.
    [J]. CECE 2014: 11TH INTERNATIONAL INTERDISCIPLINARY MEETING ON BIOANALYSIS, 2014, : 357 - 361
  • [39] The TP53 fertility network
    Paskulin, Diego d'Avila
    Paixao-Cortes, Vanessa Rodrigues
    Hainaut, Pierre
    Bortolini, Maria Catira
    Ashton-Prolla, Patricia
    [J]. GENETICS AND MOLECULAR BIOLOGY, 2012, 35 (04) : 939 - 946
  • [40] Mutation and function of TP53
    Milner, J
    [J]. BRAIN PATHOLOGY, 2000, 10 (04) : 504 - 504
12345